Skip to main content
. 2017 Sep 6;21:235. doi: 10.1186/s13054-017-1822-y

Table 2.

Secondary outcomes

Loxapine Placebo p Value
Ventilator-free days in first 14 days (SD) 5.8 (8.4) 5.5 (8.4) 0.9
Unplanned extubations, n (%) 6 (13) 7 (18) 0.5
Sedation resumption during the first 24 h, n (%) 8 (17) 17 (44) 0.01
Nosocomial pneumonia, n (%) 7 (15) 8 (21) 0.5
Mortality at 14 days, n (%) 1 (2) 2 (5) 0.6
Mortality at 6 weeks, n (%) 5 (10) 3 (8) 0.7